IVIg Exposure and Renal Failure

Project Title IVIg Exposure and Renal Failure
Date Posted
Saturday, March 7, 2015
Project ID

Modular program-based one-time assessment of IVIg and subsequent diagnosis of acute renal failure and transfusion procedures among patients with and without a new hemolysis diagnosis after exposure to IVIg. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2006 through December 31, 2012. Modular programs are adaptable standardized programs. Results were generated using Modular Program 6, version 6.0; click here for more information.  Queries were distributed in October 2013. This report includes data from 18 Data Partners.

If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Medical Product
intravenous immunoglobulin (IVIg)
Health Outcome
acute kidney failure
acute renal failure
Population / Cohort
All individuals
Time Period
2006 - 2012
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
Scroll to Top